| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 153.51B | 159.66B | 149.54B | 138.22B | 130.18B | 123.48B |
| Gross Profit | 36.31B | 38.78B | 35.44B | 33.64B | 31.92B | 30.98B |
| EBITDA | 13.60B | 14.52B | 13.30B | 12.76B | 11.86B | 12.21B |
| Net Income | 4.36B | 6.07B | 4.73B | 5.81B | 6.11B | 5.81B |
Balance Sheet | ||||||
| Total Assets | 114.05B | 114.69B | 113.95B | 114.93B | 110.78B | 105.90B |
| Cash, Cash Equivalents and Short-Term Investments | 25.22B | 26.48B | 26.89B | 31.69B | 37.01B | 36.16B |
| Total Debt | 2.05B | 3.22B | 2.65B | 2.35B | 2.87B | 3.40B |
| Total Liabilities | 27.58B | 30.26B | 28.10B | 28.14B | 28.56B | 28.38B |
| Stockholders Equity | 85.79B | 83.72B | 85.19B | 86.18B | 81.66B | 77.00B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 8.16B | 5.99B | -372.00M | 2.94B | 6.49B |
| Operating Cash Flow | 0.00 | 11.44B | 10.10B | 8.04B | 8.59B | 10.13B |
| Investing Cash Flow | 0.00 | -4.23B | -11.41B | -10.21B | -6.24B | -6.74B |
| Financing Cash Flow | 0.00 | -7.83B | -5.20B | -3.20B | -2.43B | -2.90B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥107.82B | 9.51 | ― | 2.85% | 1.06% | -7.68% | |
65 Neutral | ¥1.15T | 8.84 | ― | 3.37% | 6.51% | 30.56% | |
64 Neutral | ¥78.86B | 13.25 | ― | 2.51% | 6.77% | 33.83% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
57 Neutral | ¥36.28B | 9.56 | ― | 3.90% | 53.30% | 35.91% | |
51 Neutral | ¥392.48B | 17.81 | ― | 3.62% | 16.26% | -52.33% |